Saba Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Saba Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-491,987	Closed	-$41.2K	–	772
2023 Q1	$41.2K	Hold	491,987	–	–	﹤0.01%	567
2022 Q4	$4.3K	Hold	491,987	–	–	﹤0.01%	857
2022 Q3	$61K	Hold	491,987	–	–	﹤0.01%	812
2022 Q2	$52K	Sell	491,987 -1,350	-0.3%	-$276	﹤0.01%	910
2022 Q1	$159K	Buy	493,337 +329,315	+201%	+$133K	﹤0.01%	765
2021 Q4	$93K	Buy	+164,022	New	+$84.2K	﹤0.01%	705

Saba Capital Management's LVACW Position: Q2 2023 in Review

Saba Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 491,987 shares — an estimated $41.2K sold.

Saba Capital Management first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $159K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Saba Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Saba Capital Management sold 491,987 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $41.2K.
Saba Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
Saba Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $159K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Saba Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.